Gerard Griffioen
Chief Tech/Sci/R&D Officer at reMYND NV
Profile
Gerard Griffioen is currently the Chief Scientific Officer-Drug Discovery at reMYND NV.
He previously worked as a Principal at the University of Vienna and Katholieke Universiteit Leuven.
Dr. Griffioen obtained a doctorate degree from Vrije Universiteit Amsterdam in 1996.
Gerard Griffioen active positions
| Companies | Position | Start |
|---|---|---|
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Chief Tech/Sci/R&D Officer | - |
Former positions of Gerard Griffioen
| Companies | Position | End |
|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - |
| University of Vienna | Corporate Officer/Principal | - |
Training of Gerard Griffioen
| Vrije Universiteit Amsterdam | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Stock Market
- Insiders
- Gerard Griffioen
